chartedge_learn

chartedge_learn

Strides Pharma Science Ltd. has been in a loss-making phase for the past four years, with losses gradually decreasing since 2021. However, the stock has shown a remarkable upward rally since March 2023, closely following the 20 EMA (Exponential Moving Average). This stock is purely driven by technical momentum rather than strong fundamentals, making it a...

chartedge_learn

After its IPO, BLS-e Services Ltd experienced a notable correction, presenting a potential buying opportunity for savvy investors. The company has shown impressive growth in net income over the past few years, with figures of 31 million, 53 million, 188 million, and 313 million (inr). This consistent upward trajectory highlights the company's strong operational...